do not combine dpp-4 inhibitor with glp-1 receptor agonist guideline Mechanisms of dipeptidyl peptidase‐4 (DPP‐4) inhibitors, glucagon‐like Insights into the Roles of
Description
In support of this, when insulin is infused to healthy individuals without diabetes to levels observed in patients with T1D on insulin treatment, insulin sensitivity decreases (36)

418,419,420 This activation holds the ability to modulate food consumption by reducing food intake and conveying signals of satiety to the brain
A randomized controlled trial found that GLP-1 mimics, such as exenatide and liraglutide, had a significant weight loss effect on obese/overweight patients without diabetes (171)

Diabetes Obes Metab 26: 54745478

Saxenda is used to help with weight loss and long-term weight management in people with obesity and in certain people who are overweight
